$3.18+0.12 (+3.92%)
Hyperion DeFi, Inc.
Hyperion DeFi, Inc. in the Healthcare sector is trading at $3.18 with a market capitalization of $48M. Wall Street consensus targets $5.65 (2 analysts), implying a +77.7% move over the next 12 months. The stock is currently near its 52-week low of $2.49, remaining 32.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $244,271↓ | $496,229↑ | $302,506 | $0↓ | $14,720 |
| Gross Profit | $244,271↑ | $192,987↓ | $302,506 | $0↓ | $14,672 |
| Operating Income | -$5.04M↓ | -$4.93M↓ | -$2.67M↑ | -$8.35M↓ | -$3.03M |
| Net Income | $8.84M↑ | -$39.77M↓ | $6.63M↑ | -$8.69M↓ | -$3.48M |
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HY...
Hyperion DeFi (NASDAQ: $HYPD) is deepening its Hyperliquid (CRYPTO: $HYPE) infrastructure push through a new partne...
Hyperliquid’s HYPE token (CRYPTO: $HYPE) has already become one of crypto’s strongest trades of th...
Hyperion DeFi Inc (HYPD) raises full-year guidance by 20% despite challenges, showcasing robust DeFi strategy execution.
Hyunsu Jung: Thank you, Jason, and good morning, everyone. In our first earnings call at Hyperion DeFi, we made a promise, stating that we would set ourselves apart from other digital asset treasury companies with our comprehensive ecosystem engagement strategy. At the time, it may have been difficult for investors to understand the concept of DeFi, let alone the idea of a public company using these strategies to generate revenue.
Hyperion DeFi Inc (HYPD) reports an impressive 87% revenue growth and strategic advancements, despite facing significant treasury losses in Q4 2025.